197 related articles for article (PubMed ID: 23046238)
1. Hematopoietic stem cell transplantation for thalassemia.
Elborai Y; Uwumugambi A; Lehmann L
Immunotherapy; 2012 Sep; 4(9):947-56. PubMed ID: 23046238
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow transplantation in adults with thalassemia: Treatment and long-term follow-up.
Gaziev J; Sodani P; Polchi P; Andreani M; Lucarelli G
Ann N Y Acad Sci; 2005; 1054():196-205. PubMed ID: 16339666
[TBL] [Abstract][Full Text] [Related]
3. Matched sibling donor hematopoietic stem cell transplantation for thalassemia.
Issaragrisil S; Kunacheewa C
Curr Opin Hematol; 2016 Nov; 23(6):508-514. PubMed ID: 27518930
[TBL] [Abstract][Full Text] [Related]
4. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
5. [Haploidentical hematopoietic stem cell transplantation for beta-thalassemia major in children].
Hao WG; Sun X; Liu S; Zhao Z; Chen ZX
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jul; 11(7):546-8. PubMed ID: 19650987
[TBL] [Abstract][Full Text] [Related]
6. Allogeneic stem cell transplantation from matched related and unrelated donors in thalassemia major patients using a reduced toxicity fludarabine-based regimen.
Resnick IB; Aker M; Tsirigotis P; Shapira MY; Abdul-Hai A; Bitan M; Gesundheit B; Amar A; Ackerstein A; Samuel S; Slavin S; Or R
Bone Marrow Transplant; 2007 Nov; 40(10):957-64. PubMed ID: 17846604
[TBL] [Abstract][Full Text] [Related]
7. Hematopoietic Stem Cell Transplantation in Thalassemia.
Strocchio L; Locatelli F
Hematol Oncol Clin North Am; 2018 Apr; 32(2):317-328. PubMed ID: 29458734
[TBL] [Abstract][Full Text] [Related]
8. Unrelated donor stem cell transplantation for transfusion-dependent thalassemia.
Shenoy S; Thompson AA
Ann N Y Acad Sci; 2016 Mar; 1368(1):122-6. PubMed ID: 26999376
[TBL] [Abstract][Full Text] [Related]
9. Current Results and Future Research Priorities in Late Effects after Hematopoietic Stem Cell Transplantation for Children with Sickle Cell Disease and Thalassemia: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric Hematopoietic Stem Cell Transplantation.
Shenoy S; Angelucci E; Arnold SD; Baker KS; Bhatia M; Bresters D; Dietz AC; De La Fuente J; Duncan C; Gaziev J; King AA; Pulsipher MA; Smith AR; Walters MC
Biol Blood Marrow Transplant; 2017 Apr; 23(4):552-561. PubMed ID: 28065838
[TBL] [Abstract][Full Text] [Related]
10. Advances in the allogeneic transplantation for thalassemia.
Lucarelli G; Gaziev J
Blood Rev; 2008 Mar; 22(2):53-63. PubMed ID: 18039551
[TBL] [Abstract][Full Text] [Related]
11. Progress in hematopoietic stem cell transplantation as allogeneic cellular gene therapy in thalassemia.
Isgrò A; Gaziev J; Sodani P; Lucarelli G
Ann N Y Acad Sci; 2010 Aug; 1202():149-54. PubMed ID: 20712786
[TBL] [Abstract][Full Text] [Related]
12. Risk adopted allogeneic hematopoietic stem cell transplantation using a reduced intensity regimen for children with thalassemia major.
Hussein AA; Al-Zaben A; Ghatasheh L; Natsheh A; Hammada T; Abdel-Rahman F; Abu-Jazar H; Sharma S; Najjar R; Frangoul H
Pediatr Blood Cancer; 2013 Aug; 60(8):1345-9. PubMed ID: 23424175
[TBL] [Abstract][Full Text] [Related]
13. Haematopoietic stem cell transplantation for thalassaemia in Chinese patients.
Li CK; Lee V; Shing MM; Leung TF
Hong Kong Med J; 2009 Jun; 15(3 Suppl 3):39-41. PubMed ID: 19494396
[TBL] [Abstract][Full Text] [Related]
14. Allogeneic peripheral blood stem cell transplantation using a fludarabine-based low intensity conditioning regimen for malignant lymphoma.
Nagler A; Slavin S; Varadi G; Naparstek E; Samuel S; Or R
Bone Marrow Transplant; 2000 May; 25(10):1021-8. PubMed ID: 10828860
[TBL] [Abstract][Full Text] [Related]
15. Hematopoietic Stem Cell Transplantation in Thalassemia.
Algeri M; Lodi M; Locatelli F
Hematol Oncol Clin North Am; 2023 Apr; 37(2):413-432. PubMed ID: 36907612
[TBL] [Abstract][Full Text] [Related]
16. Unrelated donor stem cell transplantation in adult patients with thalassemia.
La Nasa G; Caocci G; Argiolu F; Giardini C; Locatelli F; Vacca A; Orofino MG; Piras E; Addari MC; Ledda A; Contu L
Bone Marrow Transplant; 2005 Dec; 36(11):971-5. PubMed ID: 16205730
[TBL] [Abstract][Full Text] [Related]
17. Allogeneic cellular gene therapy for hemoglobinopathies.
Gaziev J; Lucarelli G
Hematol Oncol Clin North Am; 2010 Dec; 24(6):1145-63. PubMed ID: 21075285
[TBL] [Abstract][Full Text] [Related]
18. French multicenter 22-year experience in stem cell transplantation for beta-thalassemia major: lessons and future directions.
Galambrun C; Pondarré C; Bertrand Y; Loundou A; Bordigoni P; Frange P; Lutz P; Mialou V; Rubie H; Socié G; Schneider P; Bernaudin F; Paillard C; Michel G; Badens C; Thuret I; ;
Biol Blood Marrow Transplant; 2013 Jan; 19(1):62-8. PubMed ID: 22892550
[TBL] [Abstract][Full Text] [Related]
19. Iron overload manifesting as apparent exacerbation of hepatic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Kamble RT; Selby GB; Mims M; Kharfan-Dabaja MA; Ozer H; George JN
Biol Blood Marrow Transplant; 2006 May; 12(5):506-10. PubMed ID: 16635785
[TBL] [Abstract][Full Text] [Related]
20. [Relationship between cellular immune function during conditioning and graft rejection in patients with beta-thalassemia major].
Hao WG; Huang SL; Sun X; Liu S
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Jul; 29(7):1375-7. PubMed ID: 19620057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
